PubRank

D E Kuhl

Author PubWeight™ 178.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997 10.06
2 Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979 5.83
3 A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995 4.44
4 Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980 3.12
5 Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994 2.76
6 Posterior cingulate cortex in Alzheimer's disease. Lancet 1994 2.11
7 Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990 2.07
8 Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med 1993 1.93
9 Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995 1.88
10 Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980 1.78
11 Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol 1982 1.77
12 Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science 1981 1.75
13 Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 1982 1.73
14 Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001 1.67
15 Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications. J Nucl Med 2000 1.54
16 Correlation methods for the centering, rotation, and alignment of functional brain images. J Nucl Med 1990 1.52
17 Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 1987 1.51
18 Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. J Cereb Blood Flow Metab 1999 1.49
19 The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983 1.47
20 Pathophysiology, treatment and outcome following severe head injury in children. Childs Brain 1979 1.46
21 Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 1982 1.43
22 Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. J Comput Assist Tomogr 1979 1.41
23 Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion. J Nucl Med 1992 1.40
24 Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991 1.40
25 N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981 1.35
26 Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 1996 1.35
27 Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 1982 1.32
28 Quantitation in positron emission computed tomography: 5. Physical--anatomical effects. J Comput Assist Tomogr 1981 1.27
29 Reorganizing data from transverse section scans of the brain using digital processing. Radiology 1968 1.26
30 Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med 1994 1.25
31 Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nucl Med Biol 1998 1.24
32 Computed tomography of intracerebral hematomas. I. Transmission CT observations on hematoma resolution. AJR Am J Roentgenol 1977 1.23
33 Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method. J Cereb Blood Flow Metab 1982 1.21
34 Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 1982 1.21
35 Dual-[11C]tracer single-acquisition positron emission tomography studies. J Cereb Blood Flow Metab 2001 1.20
36 Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med 1996 1.18
37 ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. J Nucl Med 1978 1.17
38 Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med 1982 1.17
39 Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991 1.17
40 Crossed cerebellar diaschisis: occurrence and resolution demonstrated with PET during carotid temporary balloon occlusion. AJNR Am J Neuroradiol 1992 1.16
41 Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001 1.16
42 Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. J Cereb Blood Flow Metab 1997 1.13
43 Quantitation in positron emission computed tomography: 4. Effect of accidental coincidences. J Comput Assist Tomogr 1981 1.13
44 Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. J Nucl Med 1979 1.11
45 Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J Cereb Blood Flow Metab 1999 1.11
46 Local cerebral blood volume in head-injured patients. Determination by emission computed tomography of 99mTc-labeled red cells. J Neurosurg 1980 1.10
47 Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med 1990 1.09
48 Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999 1.08
49 The brain scan in Sturge-Weber syndrome. Radiology 1972 1.08
50 PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med 1995 1.07
51 Tomographic mapping of human cerebral metabolism visual stimulation and deprivation. Neurology 1981 1.07
52 Correlation of criteria used for localizing epileptic foci in patients considered for surgical therapy of epilepsy. Ann Neurol 1981 1.05
53 Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980 1.05
54 Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol 1991 1.04
55 Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res 1999 1.03
56 Decreased striatal monoaminergic terminals in Huntington disease. Neurology 2000 1.03
57 Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 1979 1.02
58 Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases. J Cereb Blood Flow Metab 1984 1.01
59 Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Ann Neurol 1984 1.00
60 Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 1990 0.99
61 Comparison of rectilinear vertex and transverse section views in brain scanning. J Nucl Med 1970 0.99
62 An investigation of a double-tracer technique for positron computerized tomography. J Nucl Med 1982 0.98
63 [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse 1998 0.98
64 Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab 1996 0.98
65 Cerebral metabolic relationships for selected brain regions in healthy adults. J Cereb Blood Flow Metab 1984 0.97
66 PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 1992 0.97
67 Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996 0.96
68 Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 1978 0.96
69 Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endocrinol Metab 2001 0.96
70 Imaging local brain function with emission computed tomography. Radiology 1984 0.95
71 Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 1977 0.95
72 Measurement of the vital capacity and perfusion of each lung by fluoroscopy and macroaggregated albumin lung scanning. An alternative to bronchospirometry for evaluating individual lung function. Ann Intern Med 1967 0.95
73 [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. J Cereb Blood Flow Metab 1994 0.95
74 Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 1997 0.94
75 Uneven distribution of maternal and fetal placental blood flow, as demonstrated using macroaggregates, and its response to hypoxia. J Clin Invest 1967 0.93
76 Tomographic mapping of human cerebral metabolism: auditory stimulation. Neurology 1982 0.93
77 Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications. Ann N Y Acad Sci 1999 0.93
78 [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience 1995 0.93
79 Comparison of metabolic rates, language, and memory in subcortical aphasias. Brain Lang 1983 0.92
80 Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch Neurol 1995 0.91
81 Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann Neurol 1984 0.91
82 In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993 0.90
83 The effect of normal aging on patterns of local cerebral glucose utilization. Ann Neurol 1984 0.90
84 Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Res Publ Assoc Res Nerv Ment Dis 1985 0.90
85 Quantitation in positron emission computed tomography: 3 Effect of sampling. J Comput Assist Tomogr 1980 0.90
86 The Mark IV system for radionuclide computed tomography of the brain. Radiology 1976 0.89
87 Local cerebral metabolism during partial seizures. Neurology 1983 0.88
88 Characterizing brain lesions with use of transverse section scanning. Radiology 1971 0.87
89 The effect of steroids on the extravascular distribution of radiographic contrast material and technetium pertechnetate in brain tumors as determined by computed tomography. Radiology 1976 0.87
90 FDG positron emission computed tomography in a study of aphasia. Ann Neurol 1981 0.87
91 In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). Synapse 1996 0.87
92 Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. J Cereb Blood Flow Metab 1998 0.87
93 Mucociliary clearance after lung denervation and bronchial transection. J Appl Physiol 1972 0.87
94 Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 1982 0.87
95 Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology 1997 0.86
96 Transmission scanning: a useful adjunct to conventional emission scanning for accurately keying isotope deposition to radiographic anatomy. Radiology 1966 0.86
97 Correlations of glucose metabolism and structural damage to language function in aphasia. Brain Lang 1984 0.86
98 Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sci 1990 0.86
99 Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease. J Nucl Med 1996 0.85
100 In vivo imaging of the brain vesicular monoamine transporter. J Nucl Med 1995 0.85
101 Local cerebral metabolic rate for glucose during petit mal absences. Ann Neurol 1985 0.85
102 In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab 1992 0.85
103 Local cerebral blood volume determined by three-dimensional reconstruction of radionuclide scan data. Circ Res 1975 0.85
104 Tomographic mapping of human cerebral metabolism: sensory deprivation. Ann Neurol 1982 0.85
105 Positron emission tomographic evaluation of cerebral blood flow during state anxiety in simple phobia. Arch Gen Psychiatry 1989 0.84
106 Initial clinical experience with 18F-2-fluoro-2-deoxy-d-glucose for determination of local cerebral glucose utilization by emission computed tomography. Acta Neurol Scand Suppl 1977 0.84
107 Tomographic mapping of human cerebral metabolism: normal unstimulated state. Neurology 1981 0.84
108 Cerebral extraction of N-13 ammonia: its dependence on cerebral blood flow and capillary permeability -- surface area product. Stroke 1982 0.84
109 Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J Med Chem 1996 0.84
110 In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography. Circulation 1981 0.84
111 Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis. Neurology 2004 0.84
112 In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography. J Neurochem 1993 0.83
113 Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil. J Cereb Blood Flow Metab 1991 0.83
114 Cerebral glucose metabolism as a function of age in man: influence of the rate constants in the fluorodeoxyglucose method. J Cereb Blood Flow Metab 1983 0.83
115 Human cerebral metabolism studied during limitation in sensory inputs. Trans Am Neurol Assoc 1981 0.83
116 PET measures of benzodiazepine receptors in progressive supranuclear palsy. Neurology 2000 0.83
117 Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose. J Cereb Blood Flow Metab 1981 0.82
118 Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. Nucl Med Biol 1993 0.82
119 Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. Int J Rad Appl Instrum B 1989 0.82
120 Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology 1999 0.82
121 13N-labeled L-amino acids for in vivo assessment of local myocardial metabolism. J Med Chem 1981 0.82
122 Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Ann Neurol 1993 0.82
123 C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium. Am Heart J 1982 0.82
124 Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism. Cortex 1992 0.81
125 Urinary particle dynamics and vesicoureteral reflux in the human. J Urol 1970 0.81
126 A boundary method for attenuation correction in positron computed tomography. J Nucl Med 1981 0.81
127 Bone marrow scan evaluation of arthropathy in sickle cell disorders. Arch Intern Med 1976 0.81
128 Effect of ischemia on quantification of local cerebral glucose metabolic rate in man. J Cereb Blood Flow Metab 1981 0.81
129 Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. J Nucl Med 1990 0.80
130 Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991 0.80
131 Neurochemical imaging of Alzheimer's disease and other degenerative dementias. Q J Nucl Med 1998 0.80
132 Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. Arch Gen Psychiatry 1989 0.80
133 Positron tomography: "in vivo" autoradiographic approach to measurement of cerebral hemodynamics and metabolism. Acta Neurol Scand Suppl 1977 0.80
134 Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nucl Med Biol 1995 0.80
135 Electrocardiographic gating in positron emission computed tomography. J Comput Assist Tomogr 1979 0.80
136 Assessment of regional myocardial ischemia by positron-emission computed tomography. Am Heart J 1982 0.79
137 Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 1997 0.79
138 Comparison of glucose metabolism, x-ray CT, and postmortem data in a patient with multiple cerebral infarcts. Neurology 1985 0.78
139 Computed tomography of intracerebral hematomas. II. Radionuclide and transmission CT studies of the perihematoma region. AJR Am J Roentgenol 1977 0.78
140 Regional brain metabolism during seizures in humans. Adv Neurol 1983 0.78
141 Epileptic patterns of local cerebral metabolism and perfusion in man: investigation by emission computed tomography of 18F-fluorodeoxyglucose and 13N-ammonia. Trans Am Neurol Assoc 1978 0.78
142 Positron emission computed tomography in the diagnosis of dementia. Trans Am Neurol Assoc 1981 0.78
143 Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse 2001 0.78
144 The Mark 3 Scanner: a compact device for multiple-view and section scanning of the brain. Radiology 1970 0.78
145 Transverse section and rectilinear brain scanning with Tc-99-m pertechnetate. Radiology 1966 0.78
146 Pitfalls in the measurement of cerebral blood volume with computed tomography. Radiology 1976 0.78
147 Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics. J Nucl Med 1990 0.77
148 Positron tomography of the heart. Prog Nucl Med 1980 0.77
149 Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am J Psychiatry 1986 0.77
150 Brain glucose metabolism in Parkinson's disease. Adv Neurol 1990 0.77
151 Quantitative section scanning using orthogonal tangent correction. J Nucl Med 1973 0.77
152 SPECT imaging of moyamoya disease using 99mTc-HM-PAO. Comparison with computed tomography findings. J Comput Tomogr 1988 0.77
153 Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. J Cereb Blood Flow Metab 2001 0.77
154 Evaluation of [123I]isopropyliodoamphetamine as a tracer for local cerebral blood flow using direct autoradiographic comparison. J Cereb Blood Flow Metab 1982 0.77
155 Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. Am J Cardiol 1980 0.76
156 Brain scanning of children using body section techniques and pertechnetate 99m-Tc. Acta Radiol Diagn (Stockh) 1966 0.76
157 Positron computed tomography. JAMA 1982 0.76
158 Neuronal response of the hippocampal formation to injury: blood flow, glucose metabolism, and protein synthesis. Exp Neurol 1983 0.76
159 Anxiety and cerebral cortical metabolism in normal persons. Psychiatry Res 1990 0.76
160 Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. J Cereb Blood Flow Metab 1996 0.75
161 In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. J Cereb Blood Flow Metab 1996 0.75
162 Cerebellar metabolic reduction in Alzheimer's disease and data normalization. J Nucl Med 1998 0.75
163 Brain glucose metabolism and memory functions: age decrease in factor scores. J Gerontol 1985 0.75
164 Gallium-67 scans in children with solid tumors. AJR Am J Roentgenol 1976 0.75
165 Technetium pertechnetate as a thyroid scanning agent. Radiology 1968 0.75
166 Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography. J Nucl Med 1982 0.75
167 Clinical characterization of Alzheimer's disease: reliability of 'age at onset' and a new descriptor, 'age at shift'. J Geriatr Psychiatry Neurol 1989 0.75
168 Distribution of pulmonary blood flow as affected by transverse (+Gx) acceleration. J Appl Physiol 1967 0.75
169 Usefulness of [18F]-deoxyglucose local metabolic rates in aphasia. Trans Am Neurol Assoc 1979 0.75
170 Optimizing the window of an Anger camera for 99m Tc. J Nucl Med 1971 0.75
171 The urinary particle scan: a tracer technique for determination of bladder bacterial residual. Br J Urol 1972 0.75
172 [Integrated and automated data analysis for neuronal activation studies using positron emission tomography: methodology and applications]. Kaku Igaku 1994 0.75
173 Transverse-section radionuclide scanning in cisternography. J Nucl Med 1976 0.75
174 A hybrid processor for modifying and rearranging radionuclide scan data under direct observation. Radiology 1969 0.75
175 Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease. Res Publ Assoc Res Nerv Ment Dis 1985 0.75
176 The use of 99mTc labeled sulfur colloid to study particle dynamics in the urinary tract. Vesicoureteral reflux. Invest Urol 1967 0.75
177 Methotrexate-induced ventriculitis: appearance on routine radionculide scan and emission computed tomography. Clin Nucl Med 1978 0.75
178 Sensitivity and resolution in radioisotope scanning. A report to the Intermational Commission on Radiation Units and Measurements. Nucl Med (Stuttg) 1969 0.75
179 Absent splenic uptake of indium-111-oxine-labeled autologous leukocytes in functional asplenia. J Nucl Med 1991 0.75
180 Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography. Arch Neurol 1988 0.75
181 Failure to improve observer performance with scan smoothing. J Nucl Med 1972 0.75
182 The prognostic significance of a deep-wedge pattern in transverse section scanning of cerebral infarctions. Radiology 1972 0.75
183 Local cerebral metabolic rates of glucose in movement and language disorders from positron tomography. Am J Physiol 1984 0.75
184 Brain imaging of glucose utilization in convulsive disorders. Res Publ Assoc Res Nerv Ment Dis 1985 0.75
185 Emission computed tomography in the study of human epilepsy. Res Publ Assoc Res Nerv Ment Dis 1983 0.75
186 Control of oxidative degradation in 99mTc-labeled ferrous hydroxide: a simplified method. J Nucl Med 1971 0.75
187 Distribution of pulmonary blood flow in fetal and newborn lambs. Respir Physiol 1970 0.75
188 99mTc-hexamethylpropyleneamine oxime single photon emission CT in poststroke depression. Am J Psychiatry 1990 0.75
189 Giant splenomegaly in sarcoidosis demonstrated by radionuclide scintiphotography. Response to corticosteroid therapy. JAMA 1971 0.75
190 Remote, semiautomated production of F-18-labeled 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1981 0.75
191 Non-invasive, long-term, serial studies of rCBF in acute head injury. Acta Neurol Scand Suppl 1977 0.75
192 A theoretical study of quantitative flow measurements with constant infusion of short-lived isotopes. Phys Med Biol 1979 0.75
193 Perforated tape recorder for digital scan data store with grey shade and numeric readout. J Nucl Med 1966 0.75
194 Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J Cereb Blood Flow Metab 1990 0.75
195 Selective uptake of radionuclides as a basis for tumor detection. Radiol Clin North Am 1969 0.75
196 Determinations of cerebral glucose utilization in dementia using positron emission tomography. Dan Med Bull 1985 0.75